DIA is offering a virtual conference for the Advertising and Promotion Regulatory Affairs Conference that allows you to view all the session recordings from the comfort of your own home/office. Can’t make all the sessions live? You will receive access to the On-Demand library with your registration for 2 months post-conference.
DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.
This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for effective patient engagement, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory practitioners, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.
Who Should Attend
Professionals involved in:
• Regulatory Affairs
• Marketing
• Communications
• Compliance
• Medical Information and Affairs
• Legal
• Patient Engagement
Schedule At-A-Glance
PRE-EVENT PROMOTIONAL WEBINAR | WEDNESDAY, FEBRUARY 2
12:00-1:00 PM Avoid Unwanted Attention to Your Press Releases
PRIMER | FRIDAY, MARCH 4
10:00 AM-3:00 PM Drug and Biologic Ad Promo Primer
DAY ONE | TUESDAY, MARCH 8
8:00-9:30 AM Welcome, Opening Remarks, and Session 1: FDA Updates
9:30-9:40AM Session Transition
9:40-10:40 AM Session 2: From Unbranded to Branded: The Role and Risks of Disease Awareness
10:40-11:15 AM Break, Visit the Virtual Exhibit Hall
11:15-11:45 AM Power Learning: DTCTV vs Online Video Ads
11:45-11:55AM Session Transition
11:55AM- 12:55PM Session 3: Pro Tip! Effective Engagement between FDA’s OPDP/APLB/CVM and
Industry Leaders
12:55-2:00 PM Break, Visit the Virtual Exhibit Hall
2:00-2:45 PM Power Learning: PRC Best Practices
2:45-3:15 PM Break, Visit the Virtual Exhibit Hall
3:15-4:30 PM Session 4: Drug/Device Company Interactions with Patient Advocacy Groups: Working
Collaboratively and Compliantly
4:30-4:40 PM Session Transition
4:40-5:10 PM Open Discussion
DAY TWO | WEDNESDAY, MARCH 9
8:00-8:35 AM Welcome and Opening Remarks and Recent and Relevant – Insights from the DIA Ad
Promo Working Group
8:35-8:45 AM Session Transition
8:45-9:45AM Session 5: OPDP Research Update
9:45-10:15 AM Break, Visit the Virtual Exhibit Hall
10:15-11:15 AM Session 6: Global AdPromo – Scenarios and Insights on Prescription Medicines and
Medical Devices
11:15-11:25AM Session Transition
11:25 AM-12:25 PM Session 7: Intersection of Labeling and AdPromo – OPDP and Industry Perspectives
12:25-1:30 PM Break, Visit the Virtual Exhibit Hall
1:30-2:30 PM Session 8: OPDP Meet and Greet
2:30-3:00 PM Refreshments, Exhibits, and Networking Break
3:00-4:00 PM Session 9: Career Forum and Closing Remarks
Learning Objectives
At the end of this conference participants should be able to:
• Discuss the current regulatory/legal/compliance environment pertaining to the advertising and promotion of prescription drugs, vaccines,
and biologics
• Discuss the latest FDA policies, guidances, and how they apply on a practical basis to day to day oversight of advertising and
promotional materials for biopharmaceuticals and medical products
• Apply lessons from recent compliance actions to current advertising and promotion review work
• Recognize material differences for disease awareness in unbranded and branded communications
• Describe the regulatory framework for evaluating traditional and online DTC TV ads
• Describe the role and objectives of the FDA on advertising and promotion issues
• Apply key learnings and best practices shared by the panelists with their own Promotional Review Committee reviews
• Develop an understanding of the benefits and value of involving patients and caregivers in the drug and medical device development
process
• Compare AdPromo differences in specific country regulations and requirements
• Discuss the various professional growth and career opportunities available in the advertising and promotion regulatory space
For more event details, please visit the link below